Antitumour activity of pembrolizumab in advanced mucosal melanoma: a post-hoc analysis of KEYNOTE-001, 002, 006Omid Hamid, Marcus O. Butler, Antoni Ribas et al.|British Journal of Cancer|2018Cited by 177